Marrone Bio Innovations, Inc. MBII
Day range unavailable
52-week range unavailable
- Market cap
- 145.56M
- Revenue (ttm)
- 44.37M
- Profit margin
- -47.08%
- Shares out
- 182.38M
- Forward P/E
- -39.91
- Beta
- 0.36
- Analysts
- Buy
- Price target
- 1.38 (+72.9%)
- Earnings date
- Aug 15, 2022
Key statistics
- Enterprise value
- 171.62M
- PEG ratio
- -0.32
- Price / sales
- 3.28
- Price / book
- 6.38
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.50%
- Free cash flow
- -5.54M
- Total cash
- 9.36M
- Total debt
- 35.46M
- Return on equity
- -71.75%
- Short % of float
- 2.18%
- 50-day average
- 1.04
- 200-day average
- 0.87155
Analyst view
Consensus: buy
- Target (low)
- 0.90
- Target (mean)
- 1.38
- Target (high)
- 2.00
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 15, 2022
Expected Aug 15, 2022. Consensus EPS estimate -0.04.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 15, 2022 | Jun 1, 2022 | 0.00 | — | — | — |
| May 11, 2022 | Mar 1, 2022 | -0.01 | — | — | — |
| Mar 28, 2022 | Dec 1, 2021 | -0.03 | — | — | — |
| Nov 10, 2021 | Sep 1, 2021 | -0.03 | — | — | — |
| Aug 16, 2021 | Jun 1, 2021 | -0.01 | — | — | — |
| May 13, 2021 | Mar 1, 2021 | -0.02 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 2021 | Roth Capital | init | — | Buy |
| Aug 19, 2021 | Aegis Capital | main | — | Buy |
| Feb 11, 2021 | Aegis Capital | main | — | Buy |
| Aug 14, 2020 | Aegis Capital | main | — | Buy |
| Jul 28, 2020 | Canaccord Genuity | init | — | Buy |
| May 14, 2020 | Aegis Capital | main | — | Buy |
About Marrone Bio Innovations, Inc.
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Country
- United States
- Website
- marronebio.com
News
Earnings Scheduled For May 11, 2022 - 55 Biggest Movers From Yesterday
Stocks That Hit 52-Week Lows On Thursday 
Earnings Scheduled For May 13, 2021 
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies 
Stocks That Hit 52-Week Highs On Monday - 101 Biggest Movers From Friday
- Mid-Afternoon Market Update: Dow Surges 100 Points; Pro-Dex Shares Fall After Q2 Earnings
Mid-Day Market Update: Crude Oil Rises Over 1%; Document Security Systems Shares Slide - Stocks That Hit 52-Week Highs On Friday
Your note
Sign in to keep a note on MBII — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHEUNG SUPING | Chief Financial Officer | Stock Award(Grant) | Feb 6, 2022 | 65,064 |
| JOHNSON TIMOTHY B | Officer | Stock Award(Grant) | Feb 6, 2022 | 105,156 |
| LEE LARA L | Director | Conversion of Exercise of derivative security | Jul 11, 2022 | 0 |
| MAGO YOGESH | Director | Conversion of Exercise of derivative security | Jul 11, 2022 | 0 |
| MARRONE PAMELA G | Director | Stock Award(Grant) | Jul 11, 2022 | 0 |
| MCGOVERN KEITH | Director | Stock Award(Grant) | Jul 11, 2022 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Ardsley Advisory Partners | 10.05% | 18,335,767 | 14.63M | Mar 30, 2022 |
| Blackrock Inc. | 2.68% | 4,884,317 | 3.90M | Mar 30, 2022 |
| Vanguard Group, Inc. (The) | 2.49% | 4,546,049 | 3.63M | Mar 30, 2022 |
| Shay Capital LLC | 1.37% | 2,500,083 | 2.00M | Mar 30, 2022 |
| Geode Capital Management, LLC | 0.90% | 1,644,477 | 1.31M | Mar 30, 2022 |
| Primecap Management Company | 0.83% | 1,519,100 | 1.21M | Mar 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.32% | 2,405,383 | 1.92M | Mar 30, 2022 |
| iShares Russell 2000 ETF | 1.22% | 2,223,233 | 1.77M | May 30, 2022 |
| Vanguard Extended Market Index Fund | 0.78% | 1,424,715 | 1.14M | Mar 30, 2022 |
| Primecap Odyssey Aggressive Growth Fund | 0.73% | 1,325,400 | 1.06M | Apr 29, 2022 |
| SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF | 0.51% | 925,576 | 738.70K | Jun 29, 2022 |
| iShares Russell 2000 Growth ETF | 0.47% | 865,212 | 690.52K | May 30, 2022 |